Showing results (81-90 of 117) with videos related to
Sort By:
Pageof 12
Molecular Medicine Reports|July 18, 2017
Expression and subcellular localization of AT motif binding factor 1 in colon tumoursHiromi Kataoka, Yutaka Miura, Makoto Kawaguchi, et al.Molecular Cancer Therapeutics|February 21, 2014
Antitumor effects in gastrointestinal stromal tumors using photodynamic therapy with a novel glucose-conjugated chlorinMamoru Tanaka, Hiromi Kataoka, Shigenobu Yano, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 28, 2021
Relationship between gene mutations and clinicopathological features in nonampullary duodenal epithelial tumorsShigeki Fukusada, Takaya Shimura, Hiroyasu Iwasaki, et al.Case Reports in Gastroenterology|June 12, 2019
Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab TreatmentTaketo Suzuki, Tsutomu Mizoshita, Tomoya Sugiyama, et al.Journal of Gastroenterology and Hepatology|August 18, 2005
Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epitheliumTakashi Joh, Makoto Sasaki, Hiromi Kataoka, et al.Biochemical and Biophysical Research Communications|October 12, 2010
TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cellsMasahide Ebi, Hiromi Kataoka, Takaya Shimura, et al.Digestion|April 1, 2021
Relationship between Immunophenotype and Clinicopathological Findings for Superficial Nonampullary Duodenal Epithelial TumorShigeki Fukusada, Takaya Shimura, Hiroyasu Iwasaki, et al.Journal of Clinical Medicine Research|April 10, 2023
Induction Therapy With a Combination of Weekly Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Ulcerative Colitis and Failure of Conventional Agents, Biologics and Janus Kinase InhibitorSatoshi Tanida, Keiji Ozeki, Takahito Katano, et al.Gastroenterology|August 10, 2004
The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cellsSatoshi Tanida, Takashi Joh, Keisuke Itoh, et al.Gastroenterology|February 25, 2020
Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative ColitisWilliam J Sandborn, Subrata Ghosh, Julian Panes, et al.Pageof 12